Biomarkers | SHC group (n = 14) | WBC group (n = 10) | Mild HIE group (n = 7) | Control group (n = 9) |
---|---|---|---|---|
IL-6 (pg mL−1) | 49.5a (15.8–219.9) | 46.7a (33.1–413.5) | 24.7a,b (14.0–69.6) | 3.8b (2.8–6.6) |
IL-1β (pg mL−1) | 2.2 (2.1–2.3) | 2.5 (2.1–3.0) | 2.1 (2.0–2.6) | 2.1 (2.0–2.2) |
TNF-α (pg mL−1) | 15.2 (10.8–25.6) | 15.8 (13.7–41.6) | 20.3 (13.9–25.6) | 15.3 (13.1–24.4) |
NSE (μg L−1) | 0.58 (0.44–1.62) | 0.67 (0.48–2.65) | 0.49 (0.37–2.13) | 0.45 (0.36–0.51) |
S100B (ng mL−1) | 0.08 (0.07–0.09) | 0.12 (0.07–0.15) | 0.11 (0.08–0.15) | 0.07 (0.06–0.08) |
S100 (ng L−1) | 17.5a (5.6–60.4) | 15.3a (7.7–86.9) | 1.7a,b (0.8–25.6) | 1.9b (0.7–4.7) |
CKBB (ng mL−1) | 1.9 (1.5–3.0) | 2.1 (1.4–3.9) | 1.9 (1.4–2.3) | 1.4 (1.1–1.8) |
L/C ratio | 9.24a (1.32–43.89) | 3.00a (0.82–34.60) | 0.05b (0.03–0.11) | 0.04b (0.03–0.08) |